Crossmark

Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression

Crossref DOI link: https://doi.org/10.1038/gim.2016.54

Published Print: 2017-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lowther, Chelsea

Speevak, Marsha

Armour, Christine M.

Goh, Elaine S.

Graham, Gail E.

Li, Chumei

Zeesman, Susan

Nowaczyk, Malgorzata J.M.

Schultz, Lee-Anne

Morra, Antonella

Nicolson, Rob

Bikangaga, Peter

Samdup, Dawa

Zaazou, Mostafa

Boyd, Kerry

Jung, Jack H.

Siu, Victoria

Rajguru, Manjulata

Goobie, Sharan

Tarnopolsky, Mark A.

Prasad, Chitra

Dick, Paul T.

Hussain, Asmaa S.

Walinga, Margreet

Reijenga, Renske G.

Gazzellone, Matthew

Lionel, Anath C.

Marshall, Christian R.

Scherer, Stephen W.

Stavropoulos, Dimitri J.

McCready, Elizabeth

Bassett, Anne S.
License Information

Text and Data Mining valid from 2017-01-01

Text and Data Mining valid from 2017-01-01

Version of Record valid from 2022-01-19
More Information

This article is maintained by: Elsevier

Article Title: Molecular characterization of NRXN1 deletions from 19,263 clinical microarray cases identifies exons important for neurodevelopmental disease expression

Journal Title: Genetics in Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/gim.2016.54

Content Type: article

Copyright: © 2017, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics

Document is current

Any future updates will be listed below